These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 15958099)
1. Myasthenia gravis accompanied by alopecia areata: clinical and immunogenetic aspects. Suzuki S; Shimoda M; Kawamura M; Sato H; Nogawa S; Tanaka K; Suzuki N; Kuwana M Eur J Neurol; 2005 Jul; 12(7):566-70. PubMed ID: 15958099 [TBL] [Abstract][Full Text] [Related]
2. Earlier occurrence of severe alopecia areata in HLA-DRB1*11-positive patients. Marques Da Costa C; Dupont E; Van der Cruys M; Andrien M; Hidajat M; Song M; Stene JJ Dermatology; 2006; 213(1):12-4. PubMed ID: 16778420 [TBL] [Abstract][Full Text] [Related]
3. Identification of a novel HLA class II association with DQB1*0502 in an Italian myasthenic population. Baggi F; Antozzi C; Andreetta F; Confalonieri P; Ciusani E; Begovich AB; Erlich HA; Cornelio F; Mantegazza R Ann N Y Acad Sci; 1998 May; 841():355-9. PubMed ID: 9668258 [No Abstract] [Full Text] [Related]
4. Association of HLA-DR/DQ polymorphism with myasthenia gravis in Tunisian patients. Fekih-Mrissa N; Klai S; Zaouali J; Gritli N; Mrissa R Clin Neurol Neurosurg; 2013 Jan; 115(1):32-6. PubMed ID: 22521184 [TBL] [Abstract][Full Text] [Related]
5. The protective role of the HLA-DR locus in patients with various clinical types of alopecia areata. Broniarczyk-Dyła G; Prusińska-Bratoś M; Dubla-Berner M; Arkuszewska C; Borowiec M; Kowalski ML; Woszczek G Arch Immunol Ther Exp (Warsz); 2002; 50(5):333-6. PubMed ID: 12455867 [TBL] [Abstract][Full Text] [Related]
6. Heterogeneous immunogenetic background in Japanese adults with myasthenia gravis. Suzuki S; Kuwana M; Yasuoka H; Tanaka K; Fukuuchi Y; Kawakami Y J Neurol Sci; 2001 Aug; 189(1-2):59-64. PubMed ID: 11535234 [TBL] [Abstract][Full Text] [Related]
7. HLA class II antigen associations help to define two types of alopecia areata. Colombe BW; Price VH; Khoury EL; Garovoy MR; Lou CD J Am Acad Dermatol; 1995 Nov; 33(5 Pt 1):757-64. PubMed ID: 7593774 [TBL] [Abstract][Full Text] [Related]
8. A variant of childhood-onset myasthenia gravis: HLA typing and clinical characteristics in Japan. Shinomiya N; Nomura Y; Segawa M Clin Immunol; 2004 Feb; 110(2):154-8. PubMed ID: 15003812 [TBL] [Abstract][Full Text] [Related]
9. Genetic association of HLA-DQB1 and HLA-DRB1 polymorphisms with alopecia areata in the Italian population. Megiorni F; Pizzuti A; Mora B; Rizzuti A; Garelli V; Maxia C; Carlesimo M; Fotruna MC; Delle Chiaie R; Cavaggioni G; Rossi A Br J Dermatol; 2011 Oct; 165(4):823-7. PubMed ID: 21692766 [TBL] [Abstract][Full Text] [Related]
11. HLA class II alleles in patients with alopecia areata. Akar A; Orkunoglu E; Sengül A; Ozata M; Gür AR Eur J Dermatol; 2002; 12(3):236-9. PubMed ID: 11978563 [TBL] [Abstract][Full Text] [Related]
12. Human Leucocyte Antigen B50 Is Associated with Conversion to Generalized Myasthenia Gravis in Patients with Pure Ocular Onset. Tiftikcioglu BI; Uludag IF; Zorlu Y; Pirim İ; Sener U; Tokucoglu F; Korucuk M Med Princ Pract; 2017; 26(1):71-77. PubMed ID: 27802446 [TBL] [Abstract][Full Text] [Related]
13. HLA class II alleles in long-standing alopecia totalis/alopecia universalis and long-standing patchy alopecia areata differentiate these two clinical groups. Colombe BW; Price VH; Khoury EL; Lou CD J Invest Dermatol; 1995 May; 104(5 Suppl):4S-5S. PubMed ID: 7738393 [No Abstract] [Full Text] [Related]
14. HLA-D locus associations in alopecia areata. DRw52a may confer disease resistance. Duvic M; Hordinsky MK; Fiedler VC; O'Brien WR; Young R; Reveille JD Arch Dermatol; 1991 Jan; 127(1):64-8. PubMed ID: 1670917 [TBL] [Abstract][Full Text] [Related]